35 results
S-3ASR
BEAM
Beam Therapeutics Inc
27 Feb 24
Automatic shelf registration
6:10pm
, as well as an innovative, platform business model that will expand the reach of our programs to more patients. Overall, we are seeking to build … of base editing programs against distinct, genetically validated editing targets, as well as an innovative, platform business model that will expand
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:55am
therapeutic impact Strategic Deals resulting in $675M upfront and more than $1B in potential milestones Innovator Deals gaining rights to innovative
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
14 Dec 23
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
4:05pm
and team as we work to bring these innovative therapies to patients.”
About Beam Therapeutics
Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company
8-K
EX-99.2
pb251 4fw7p1m0
19 Oct 23
Cost Associated with Exit or Disposal Activities
8:50am
8-K
EX-99.1
l54o2t3 8qi57yhv7h9
8 Aug 23
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
7:11am
8-K
EX-99.1
osdpea32ci
10 Aug 21
Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results
6:46am
8-K
EX-99.1
948pxem
23 Feb 21
Beam Therapeutics Announces Acquisition of Guide Therapeutics
8:43am